Article Data

  • Views 326
  • Dowloads 141

Review

Open Access

Spinal cord injury and neurogenic lower urinary tract dysfunction: what do we know and where are we going?

  • William Dodd1
  • Kartik Motwani1
  • Coulter Small1
  • Kevin Pierre1
  • Devan Patel1
  • Samuel Malnik1
  • Brandon Lucke-Wold1,*,
  • Ken Porche1

1Department of Neurosurgery, University of Florida, Gainesville, FL 32601, USA

DOI: 10.31083/j.jomh1801024 Vol.18,Issue 1,January 2022 pp.1-6

Submitted: 17 September 2021 Accepted: 20 October 2021

Published: 31 January 2022

*Corresponding Author(s): Brandon Lucke-Wold E-mail: brandon.luckewold@gmail.com

Abstract

One of the well reported but difficult to manage symptoms of spinal cord injury (SCI) is neurogenic lower urinary tract dysfunction (NLUTD). The type of NLUTD is variable based on location and extent of injury. SCI affects more males and NLUTD is especially debilitating for men with incomplete injury. This review summarizes the anatomical basis of NLUTD in SCI and discusses current diagnostic and management strategies that are being utilized clinically. The last two sections address new innovations and emerging discoveries with the goal of increasing scientific interest in improving treatment options for people with SCI. Areas warranting further investigation are pinpointed to address current gaps in knowledge and/or appropriate technology.


Keywords

Spinal cord injury; Neurogenic lower urinary tract dysfunction; Diagnostics; Neurostimulation; Emerging discoveries

Cite and Share

William Dodd,Kartik Motwani,Coulter Small,Kevin Pierre,Devan Patel,Samuel Malnik,Brandon Lucke-Wold,Ken Porche. Spinal cord injury and neurogenic lower urinary tract dysfunction: what do we know and where are we going?. Journal of Men's Health. 2022. 18(1);1-6.

References

[1] Hou S, Rabchevsky AG. Autonomic consequences of spinal cord injury. Comprehensive Physiology. 2014; 4: 1419–1453.

[2] DeVivo MJ. Epidemiology of traumatic spinal cord injury: trends and future implications. Spinal Cord. 2012; 50: 365–372.

[3] Milligan J, Goetz LL, Kennelly MJ. A Primary Care Provider’s Guide to Management of Neurogenic Lower Urinary Tract Dys-function and Urinary Tract Infection after Spinal Cord Injury. Topics in Spinal Cord Injury Rehabilitation. 2020; 26: 108–115.

[4] Vining RD, Gosselin DM, Thurmond J, Case K, Bruch FR. Inter-disciplinary rehabilitation for a patient with incomplete cervical spinal cord injury and multimorbidity: a case report. Medicine. 2017; 96: e7837.

[5] Skeers P, Battistuzzo CR, Clark JM, Bernard S, Freeman BJC, Batchelor PE. Acute Thoracolumbar Spinal Cord Injury: Rela-tionship of Cord Compression to Neurological Outcome. The Journal of Bone and Joint Surgery. American Volume. 2018; 100: 305–315.

[6] Hamid R, Averbeck MA, Chiang H, Garcia A, Al Mousa RT, Oh S, et al. Epidemiology and pathophysiology of neurogenic bladder after spinal cord injury. World Journal of Urology. 2018; 36: 1517–1527.

[7] Stoffel JT. Detrusor sphincter dyssynergia: a review of physiol-ogy, diagnosis, and treatment strategies. Translational Androl-ogy and Urology. 2016; 5: 127–135.

[8] Adriaansen JJE, van Asbeck FWA, Tepper M, Faber WX, Visser-Meily JMA, de Kort LMO, et al. Bladder-emptying methods, neurogenic lower urinary tract dysfunction and impact on quality of life in people with long-term spinal cord injury. The Journal of Spinal Cord Medicine. 2017; 40: 43–53.

[9] Dorsher PT, McIntosh PM. Neurogenic bladder. Advances in Urology. 2012; 2012: 816274.

[10] Bryk DJ, Zhao LC. Guideline of guidelines: a review of urolog-ical trauma guidelines. BJU International. 2016; 117: 226–234.

[11] Kessler TM, Traini LR, Welk B, Schneider MP, Thavaseelan J, Curt A. Early neurological care of patients with spinal cord in-jury. World Journal of Urology. 2018; 36: 1529–1536.

[12] Sekido N, Igawa Y, Kakizaki H, Kitta T, Sengoku A, Takahashi S, et al. Clinical guidelines for the diagnosis and treatment of lower urinary tract dysfunction in patients with spinal cord in-jury. International Journal of Urology. 2020; 27: 276–288.

[13] Alsulihem A, Corcos J. Evaluation, treatment, and surveillance of neurogenic detrusor overactivity in spinal cord injury patients. Neuroimmunology and Neuroinflammation. 2019; 6: 13.

[14] Bright E, Cotterill N, Drake M, Abrams P. Developing a vali-dated urinary diary: phase 1. Neurourology and Urodynamics. 2012; 31: 625–633.

[15] Selius BA, Subedi R. Urinary retention in adults: diagnosis and initial management. American Family Physician. 2008; 77: 643–650.

[16] Liao L, Zhang F, Chen G. New grading system for upper uri-nary tract dilation using magnetic resonance urography in pa-tients with neurogenic bladder. BMC Urology. 2014; 14: 38.

[17] Wyndaele J. The management of neurogenic lower urinary tract dysfunction after spinal cord injury. Nature Reviews. Urology. 2016; 13: 705–714.

[18] Wyndaele JJ. Intermittent catheterization: which is the optimal technique? Spinal Cord. 2002; 40: 432–437.

[19] Burns AS, Rivas DA, Ditunno JF. The Management of Neurogenic Bladder and Sexual Dysfunction after Spinal Cord Injury. Spine. 2001; 26: S129–S136.

[20] Lucas E. Medical Management of Neurogenic Bladder for Children and Adults: a Review. Topics in Spinal Cord Injury Rehabilitation. 2019; 25: 195–204.

[21] Kakizaki H, Ameda K, Kobayashi S, Tanaka H, Shibata T, Koyanagi T. Urodynamic effects of alpha1-blocker tamsulosin on voiding dysfunction in patients with neurogenic bladder. International Journal of Urology. 2003; 10: 576–581.

[22] Chancellor MB, Erhard MJ, Hirsch IH, Stass WE. Prospective evaluation of terazosin for the treatment of autonomic dysreflexia. The Journal of Urology. 1994; 151: 111–113.

[23] Madhuvrata P, Singh M, Hasafa Z, Abdel-Fattah M. Anticholinergic drugs for adult neurogenic detrusor overactivity: a systematic review and meta-analysis. European Urology. 2012; 62: 816–830.

[24] Sager C, Sanmartino M, Burek C, Gomez YR, Vazquez Patiño M, Weller S, et al. Efficacy and safety of Mirabegron as adju-vant treatment in children with refractory neurogenic bladder dysfunction. Journal of Pediatric Urology. 2020; 16: 655.e1– 655. e6.

[25] El Helou E, Labaki C, Chebel R, El Helou J, Abi Tayeh G, Jalkh G, et al. The use of mirabegron in neurogenic bladder: a system-atic review. World Journal of Urology. 2020; 38: 2435–2442.

[26] Thaker H, Zhang S, Diamond DA, Dong M. Beyond botulinum neurotoxin a for chemodenervation of the bladder. Current Opin-ion in Urology. 2021; 31: 140–146.

[27] Martens FMJ, Sievert K. Neurostimulation in neurogenic pa-tients. Current Opinion in Urology. 2020; 30: 507–512.

[28] Sauerwein D. Surgical treatment of spastic bladder paralysis in paraplegic patients. Sacral deafferentation with implantation of a sacral anterior root stimulator. Der Urologe. Ausg. A. 1990; 29: 196–203.

[29] Van Kerrebroeck PE, Koldewijn EL, Rosier PF, Wijkstra H, De-bruyne FM. Results of the treatment of neurogenic bladder dys-function in spinal cord injury by sacral posterior root rhizotomy and anterior sacral root stimulation. The Journal of Urology. 1996; 155: 1378–1381.

[30] Martens FMJ, Heesakkers JPFA. Clinical results of a brindley procedure: sacral anterior root stimulation in combination with a rhizotomy of the dorsal roots. Advances in Urology. 2011; 2011: 709708.

[31] Hohenfellner M, Pannek J, Bötel U, Dahms S, Pfitzenmaier J, Fichtner J, et al. Sacral bladder denervation for treatment of de-trusor hyperreflexia and autonomic dysreflexia. Urology. 2001; 58: 28–32.

[32] Samson G, Cardenas DD. Neurogenic Bladder in Spinal Cord Injury. Physical Medicine and Rehabilitation Clinics of North America. 2007; 18: 255–274.

[33] Wille S, Schumacher P, Paas J, Tenholte D, Eminaga O, Müller U, et al. Catheterless long-term ambulatory urodynamic mea-surement using a novel three-device system. PLoS ONE. 2014; 9: e96280.

[34] Liu L, Zhao K, Chen F, Wu J, Yang Z, Chen M, et al. Testing of a New Portable Device for Dynamic Bladder Pressure Monitor-ing. Lower Urinary Tract Symptoms. 2018; 10: 193–197.

[35] Soebadi MA, Weydts T, Brancato L, Hakim L, Puers R, De Rid-der D. Novel implantable pressure and acceleration sensor for bladder monitoring. International Journal of Urology. 2020; 27: 543–550.

[36] Parittotokkaporn S, Varghese C, O’Grady G, Lawrence A, Svirskis D, O’Carroll SJ. Transcutaneous Electrical Stimulation for Neurogenic Bladder Dysfunction Following Spinal Cord In-jury: Meta-Analysis of Randomized Controlled Trials. Neuro-modulation. 2021; 24: 1237–1246.

[37] de Abreu GE, de Souza LA, da Fonseca MLV, Barbosa TBC, de Mello ERD, Nunes ANB, et al. Parasacral Transcutaneous Electrical Nerve Stimulation for the Treatment of Children and Adolescents with Bladder and Bowel Dysfunction: a Random-ized Clinical Trial. Journal of Urology. 2021; 205: 1785–1791.

[38] Darrow D, Balser D, Netoff TI, Krassioukov A, Phillips A, Parr A, et al. Epidural Spinal Cord Stimulation Facilitates Immedi-ate Restoration of Dormant Motor and Autonomic Supraspinal Pathways after Chronic Neurologically Complete Spinal Cord Injury. Journal of Neurotrauma. 2019; 36: 2325–2336.

[39] Park E, Lee J, Kang M, Cho K, Cho BH, Lee K. Detecting Blad-der Biomarkers for Closed-Loop Neuromodulation: a Techno-logical Review. International Neurourology Journal. 2018; 22: 228–236.

[40] Schäfer W, Abrams P, Liao L, Mattiasson A, Pesce F, Spang-berg A, et al. Good urodynamic practices: uroflowmetry, filling cystometry, and pressure-flow studies. Neurourology and Uro-dynamics. 2002; 21: 261–274.

[41] Yu L, Kim BJ, Meng E. Chronically implanted pressure sensors: challenges and state of the field. Sensors. 2014; 14: 20620–20644.

[42] Kirkham APS, Knight SL, Craggs MD, Casey ATM, Shah PJR. Neuromodulation through sacral nerve roots 2 to 4 with a Finetech-Brindley sacral posterior and anterior root stimulator. Spinal Cord. 2002; 40: 272–281.

[43] Yiou R, Audureau E, Loche C, Dussaud M, Lingombet O, Bin-has M. Comprehensive evaluation of embarrassment and pain associated with invasive urodynamics. Neurourology and Uro-dynamics. 2015; 34: 156–160.

[44] Abelson B, Majerus S, Sun D, Gill BC, Versi E, Damaser MS. Ambulatory urodynamic monitoring: state of the art and future directions. Nature Reviews Urology. 2019; 16: 291–301.

[45] Nasrabadi MZ, Tabibi H, Salmani M, Torkashvand M, Zarepour E. A comprehensive survey on non-invasive wearable bladder volume monitoring systems. Medical and Biological Engineer-ing and Computing. 2021; 59: 1373–1402.

[46] Basu AS, Majerus S, Ferry E, Makovey I, Zhu H, Damaser MS. Is submucosal bladder pressure monitoring feasible? Proceed-ings of the Institution of Mechanical Engineers. 2019; 233: 100–113.

[47] Peh WYX, Mogan R, Thow XY, Chua SM, Rusly A, Thakor NV, et al. Novel Neurostimulation of Autonomic Pelvic Nerves Overcomes Bladder-Sphincter Dyssynergia. Frontiers in Neuro-science. 2018; 12: 186.


Abstracted / indexed in

Science Citation Index Expanded (SciSearch) Created as SCI in 1964, Science Citation Index Expanded now indexes over 9,200 of the world’s most impactful journals across 178 scientific disciplines. More than 53 million records and 1.18 billion cited references date back from 1900 to present.

Journal Citation Reports/Science Edition Journal Citation Reports/Science Edition aims to evaluate a journal’s value from multiple perspectives including the journal impact factor, descriptive data about a journal’s open access content as well as contributing authors, and provide readers a transparent and publisher-neutral data & statistics information about the journal.

Directory of Open Access Journals (DOAJ) DOAJ is a unique and extensive index of diverse open access journals from around the world, driven by a growing community, committed to ensuring quality content is freely available online for everyone.

SCImago The SCImago Journal & Country Rank is a publicly available portal that includes the journals and country scientific indicators developed from the information contained in the Scopus® database (Elsevier B.V.)

Publication Forum - JUFO (Federation of Finnish Learned Societies) Publication Forum is a classification of publication channels created by the Finnish scientific community to support the quality assessment of academic research.

Scopus CiteScore 0.7 (2021) Scopus is Elsevier's abstract and citation database launched in 2004. Scopus covers nearly 36,377 titles (22,794 active titles and 13,583 Inactive titles) from approximately 11,678 publishers, of which 34,346 are peer-reviewed journals in top-level subject fields: life sciences, social sciences, physical sciences and health sciences.

Norwegian Register for Scientific Journals, Series and Publishers Search for publication channels (journals, series and publishers) in the Norwegian Register for Scientific Journals, Series and Publishers to see if they are considered as scientific. (https://kanalregister.hkdir.no/publiseringskanaler/Forside).

Submission Turnaround Time

Conferences

Top